EMAS position statement: Testosterone replacement therapy in the aging male

Yazar
van der Schouw, Yvonne T.
Depypere, Herman
Lambrinoudaki, Irene
Goulis, Dimitrios G.
Stute, Petra
Stevenson, John C.
Mueck, Alfred
Perez-Lopez, Faustino R.
Rees, Margaret
Simonsini, Tommaso
Senturk, Levent M.
Dimopoulou, Christina
Ceausu, Iuliana
Üst veri
Tüm öğe kaydını göster
Özet
Introduction: Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, characterized by the presence of symptoms (most usually of a sexual nature, such as decreased libido, decreased spontaneous erections and erectile dysfunction) and signs, in combination with low serum testosterone concentrations. Whether testosterone replacement therapy (TRT) should be offered to those individuals is still under extensive debate.
Bağlantı
http://hdl.handle.net/20.500.12627/16875
https://doi.org/10.1016/j.maturitas.2015.11.003
Koleksiyonlar